The Chairman of the Pharmaceutical Authority accompanies 11 American ambassadors to visit the Egyptian city of medicine
Dr. Ali Al -Ghamrawi, Chairman of the Egyptian Pharmaceutical Authority, accompanied today a high -level delegation that includes 11 ambassadors from Latin American countries, during their visit to the Egyptian city of Medicine, Vetot Pharma & quot;; This is in the context of enhancing the means of joint cooperation between Egypt and Latin American countries in the field of pharmaceutical industries, and they were received & nbsp; Dr. Amr Mamdouh, Chairman and Managing Director of the Egyptian Medicine City & quot; Pope Pharma & quot; in the presence of Ambassador Ashraf Mounir, Deputy Assistant Foreign Minister for Latin America and Dr. Mohi Hafez, Chairman of the Export Council Medical Industries, and Dr. Yousry Nawar, Chairman of the Pharmaceutical Industries Committee of the American Trade Chamber And attended by Dr. Yassi Rajaei, Assistant Chairman The central administration of the office of the Chairman of the Commission, and Dr. Osama Hatem, the assistant head of the authority and supervisor of the Central Administration for Pharmaceutical Policy. & nbsp;
During his speech, the head of the Egyptian Drug Authority welcomed the ambassadors, confirming the depth of ties between the Arab Republic of Egypt and Latin countries, and the Egyptian Drug Authority was keen to expand the horizons of joint cooperation; In a way that contributes to strengthening strategic partnerships and opening new markets for Egyptian pharmaceutical products, and praised the huge industrial components that Egypt enjoys in the pharmaceutical sector, and the remarkable growth in the sector in recent years, which made Egypt become the first state regional in achieving drug self -sufficiency at a rate of 91.3% And that Egypt issues more than 147 countries around the world, and that the drug body has obtained more than 11 dependence International during the past five years. ” To reach 3 billion dollars by 2030, which reflects Egypt’s ability to compete Globally. Being the first organizational body in Africa to obtain the third maturity level by the World Health Organization as the first African country to achieve this achievement in the manufacture of medicines and vaccines; This classification is a great achievement that highlights the commitment of the Egyptian Drug Authority to apply the highest international standards in the pharmaceutical industry sector and ensure the quality of health products, and that Egyptian companies are keen to find international cooperation in the fields of Emiratization and the transfer of modern technology, global competitiveness and export. ” In light of the Egyptian Pharmaceutical Authority recently obtaining the approval of the World Health Organization in the field of medicines. & nbsp;
For his part, Dr. Amr Mamdouh, Chairman and Managing Director of the Egyptian Medication City & quot; Gpto Pharma & quot; The Egyptian city of medicine is a manufacturing edifice owned by the state and came in implementation of the vision and directives of the political leadership in order to provide a safe and effective medicine and in high quality and at reasonable prices, through the localization of chronic, modern and innovative drugs, and that the goal is to cover local needs through the policy of resettlement, open export horizons, and that the city is Partnership agreements with major global manufacturing companies have been concluded, and we look forward to cooperation with Latin American countries In joint manufacturing and export of high -quality drugs, indicating that the current drug production volume is 65 million packages annually. & nbsp;
As Ambassador Ashraf Mounir, Deputy Assistant Foreign Minister for Latin America, confirmed that the Egyptian drug has global quality and competitive prices less than its counterparts in other countries, and therefore this competitive advantage opens the Latin markets to it, and efforts are integrated Between all state agencies to reach the achievement of the desired increase in the exports of the drug, and that the Egyptian state with all its governmental institutions and industry partners seeking to seek To meet the needs of the large drug market in South America, and that the visit comes within the framework of efforts to show Egyptian capabilities in manufacturing and ready for export. & nbsp;
The diplomatic delegation praised the capabilities of the Egyptian pharmaceutical system, and welcomed the development of drug relations with the Arab Republic of Egypt, expressing their appreciation for the distinguished capabilities and modern technology enjoyed by the Egyptian city of medicine. Various drug fields.
During the visit, ambassadors were delivered Seven countries are examples of a project of understanding notes, just as they were signed with Argentina, Panama and Brazil. & nbsp; This came within the framework of the continuous endeavor of the Authority to enhance the ways of cooperation with the Latin American countries, and in support of the efforts to create strategic partnerships that contribute to achieving the permeability of the Egyptian drug for all international markets, in line with the Egyptian state’s strategy to support the national economy and increase exports.
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and
